Literature DB >> 21963141

Genetic variations in CYP17A1, CACNB2 and PLEKHA7 are associated with blood pressure and/or hypertension in She ethnic minority of China.

Yinghua Lin1, Xiaolan Lai, Bin Chen, Yuan Xu, Baoying Huang, Zichun Chen, Shaoheng Zhu, Jin Yao, Qiqin Jiang, Huibin Huang, Junping Wen, Gang Chen.   

Abstract

OBJECTIVES: Two large-scale genome-wide association studies (GWAs) have identified multiple variants associated with blood pressure (BP) or hypertension. The present study was to investigate whether some variations were associated with BP traits and hypertension or even prehypertension in adult She ethnic minority of China.
METHODS: The population of the present study comprised 4460 (1979 males and 2481 females, respectively) unrelated she ethnic minority based on a cross-sectional study from Ningde City in Fujian province of China. There were 1692 hypertensives, 1600 prehypertensives and 1168 normotensive controls, respectively. We genotyped 7 variants in CYP17A1, PLEKHA7, CACNB2, ATP2B1, TBX3-TBX5, CSK-ULK3 and SH2B3 reported by the previous GWAs on Europeans. All analyses were performed in an additive genetic model.
RESULTS: As the minor allele of rs653178 in/near SH2B3 was very rare with the frequency of 0.018, we excluded this single nucleotide polymorphism (SNP) in the further analyses. Of the other 6 loci, linear regression analyses revealed that rs11191548 in CYP17A1 and rs11014166 in CACNB2 were significantly associated with systolic BP (β = -1.17, P = 0.002 and β = -0.50, P = 0.006, respectively), while only SNP rs11191548 was significantly associated with diastolic BP (β = -0.56, P=0.002) after adjusted by age, sex and BMI. Two variants in CACNB2 and PLEKHA7 were found to be significantly related to hypertension (odds ratios [OR] and (95% confidence interval [CI]): 0.79 (0.65-0.97) and 1.19 (1.01-1.41), respectively) in logistic regression analyses after adjusted by age, sex and BMI. In addition, we found that combined risk alleles of the 6 SNPs increased risk of hypertension in a stepwise fashion (P for trend < 0.001). However, none of the 6 SNPs was significantly associated with BMI or prehypertension status. While logistic analysis showed that subjects with cumulative risk alleles more than 9 had significantly higher risk for prehypertension (adjusted OR: 3.10, P < 0.001) compared with those with risk alleles less than 4.
CONCLUSIONS: We replicated that variations in CYP17A1, CACNB2 and PLEKHA7 were related to BP traits and/or hypertension in She population. In addition, although we failed to observe single gene associated with prehypertension, we first found that conjoint effect of multiple risk alleles on BP might increase the risk of progressing to prehypertension.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21963141     DOI: 10.1016/j.atherosclerosis.2011.09.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  30 in total

1.  CYP17A1 Enzyme Activity Is Linked to Ambulatory Blood Pressure in a Family-Based Population Study.

Authors:  Daniel Ackermann; Menno Pruijm; Belen Ponte; Idris Guessous; Georg Ehret; Geneviève Escher; Bernhard Dick; Heba Al-Alwan; Philippe Vuistiner; Fred Paccaud; Michel Burnier; Antoinette Péchère-Bertschi; Pierre-Yves Martin; Bruno Vogt; Markus Mohaupt; Murielle Bochud
Journal:  Am J Hypertens       Date:  2015-08-20       Impact factor: 2.689

Review 2.  A Review of the Genetics of Hypertension with a Focus on Gene-Environment Interactions.

Authors:  R J Waken; Lisa de Las Fuentes; D C Rao
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

3.  Mutation of Plekha7 attenuates salt-sensitive hypertension in the rat.

Authors:  Bradley T Endres; Jessica R C Priestley; Oleg Palygin; Michael J Flister; Matthew J Hoffman; Brian D Weinberg; Michael Grzybowski; Julian H Lombard; Alexander Staruschenko; Carol Moreno; Howard J Jacob; Aron M Geurts
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

4.  Common variant rs11191548 near the CYP17A1 gene is associated with hypertension and the serum 25(OH) D levels in Han Chinese.

Authors:  Ning Zhang; Jian Jia; Qiuju Ding; Huimei Chen; Xiaoman Ye; Haixia Ding; Yiyang Zhan
Journal:  J Hum Genet       Date:  2018-03-19       Impact factor: 3.172

5.  Relationship between CYP17A1 Genetic Polymorphism and Essential Hypertension in a Chinese Population.

Authors:  Chuan-Fang Dai; Xiang Xie; Yi-Tong Ma; Yi-Ning Yang; Xiao-Mei Li; Zhen-Yan Fu; Fen Liu; Bang-Dang Chen; Min-Tao Gai
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

Review 6.  Genetics of Human Primary Hypertension: Focus on Hormonal Mechanisms.

Authors:  Worapaka Manosroi; Gordon H Williams
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

7.  PLEKHA7 Recruits PDZD11 to Adherens Junctions to Stabilize Nectins.

Authors:  Diego Guerrera; Jimit Shah; Ekaterina Vasileva; Sophie Sluysmans; Isabelle Méan; Lionel Jond; Ina Poser; Matthias Mann; Anthony A Hyman; Sandra Citi
Journal:  J Biol Chem       Date:  2016-04-04       Impact factor: 5.157

Review 8.  Druggable targets in the Rho pathway and their promise for therapeutic control of blood pressure.

Authors:  Rachel A Dee; Kevin D Mangum; Xue Bai; Christopher P Mack; Joan M Taylor
Journal:  Pharmacol Ther       Date:  2018-09-04       Impact factor: 12.310

Review 9.  Towards Precision Medicine for Hypertension: A Review of Genomic, Epigenomic, and Microbiomic Effects on Blood Pressure in Experimental Rat Models and Humans.

Authors:  Sandosh Padmanabhan; Bina Joe
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

10.  Common Polymorphisms at the CYP17A1 Locus Associate With Steroid Phenotype: Support for Blood Pressure Genome-Wide Association Study Signals at This Locus.

Authors:  Louise A Diver; Scott M MacKenzie; Robert Fraser; Frances McManus; E Marie Freel; Samantha Alvarez-Madrazo; John D McClure; Elaine C Friel; Neil A Hanley; Anna F Dominiczak; Mark J Caulfield; Patricia B Munroe; John M Connell; Eleanor Davies
Journal:  Hypertension       Date:  2016-02-22       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.